Latest stories on EVGN
Evogene to Participate in Upcoming BIO-Europe in Germany and Drug Discovery Chemistry Europe in Spain
StockTitan52 · neutralproduct/pr
Evogene to Participate in U.S. East Coast AI Drug Discovery Roadshow Organized by the Israel Export Institute and TradeIL
StockTitan56 · neutralproduct/pr
Evogene Strikes Governance Deal With Pure Capital Group, Reconstitutes Board
TipRanks55 · neutralgeneral
Evogene announces cooperation agreement with Pure Capital Group
The Fly56 · neutralgeneral
Evogene and Pure Capital Group Reach Cooperation Agreement to Resolve Differences and Reconstitute Board of Directors
PR Newswire55 · neutralgeneral
Evogene receives non-compliance letter from Nasdaq
The Fly38 · neutralgeneral
Evogene Reports Nasdaq Grants Additional 180-Day Period to Regain Minimum Bid Price Compliance
PR Newswire50 · neutralgeneral
Evogene GAAP EPS of -$0.63, revenue of $0.68M
Seeking Alpha28 · bearishearnings
Evogene responds to latest communication from L.I.A. Pure Capital, Invest-Pro
The Fly54 · neutralgeneral
Evogene Responds to Dissident Shareholders: Transformation and Commercial Progress Provide a Clear Path Forward
PR Newswire56 · neutralgeneral
Evogene (EVGN) Q2 2026 Earnings Call Transcript
The Motley Fool63 · neutralearnings
Evogene’s director nominees recommended by ISS and Glass Lewis
The Fly50 · neutralgeneral
Evogene Ltd. Q2 2026 Earnings Call Summary
Yahoo Finance50 · neutralearnings
Evogene Ltd. (EVGN) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Evogene Reports Second Quarter and First Half 2026 Financial Results
PR Newswire53 · neutralearnings
Evogene Deepens AI-Driven Transformation as Second-Quarter Loss Narrows and ChemPass Platform Expands
TipRanks56 · neutralearnings
Evogene GAAP EPS of -$0.13 beats by $0.14, revenue of $0.35M beats by $0.02M
Seeking Alpha68 · bullishearnings
Evogene Q2 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Evogene Chairman Nir Nimrodi to Join Quarterly Results Call to Address Current Dissident Shareholders Situation
PR Newswire50 · neutralgeneral
Evogene Schedules Second Quarter 2026 Financial Results Release
PR Newswire50 · neutralgeneral
Evogene Schedules Second Quarter 2026 Financial Results Release
StockTitan50 · neutralgeneral
Evogene and Tel Aviv University Launch AI-Driven Partnership Targeting Early-Stage Drug Discovery Barriers
MarketChameleon63 · neutralproduct/pr
Evion Group Performance Rights Vest After Market Cap Milestone
TipRanks58 · neutralgeneral